Lupus is a chronic autoimmune disease, meaning the immune system mistakenly attacks the body’s own healthy tissues instead of fighting off infections. The most common form, systemic lupus erythematosus (SLE), can affect nearly any organ in the body, including the skin, joints, kidneys, heart, and brain. About 204,000 people in the United States have SLE, and 9 out of 10 of them are women.
How Lupus Works in the Body
In a healthy immune system, the body produces antibodies that target viruses, bacteria, and other invaders. In lupus, the immune system produces autoantibodies that react with the body’s own cell components, particularly the DNA and proteins inside cell nuclei. These autoantibodies latch onto cellular material and form clumps called immune complexes, which then deposit in tissues throughout the body. Wherever those complexes land, they trigger inflammation and damage.
This is why lupus can show up in so many different places. The immune complexes can settle in the kidneys, the lining of the heart, the joints, or the blood vessels. The body essentially treats its own tissues as foreign threats, launching an inflammatory attack that causes the wide-ranging symptoms lupus is known for.
The Four Types of Lupus
Systemic lupus erythematosus (SLE) is what most people mean when they say “lupus.” It can range from mild to severe and potentially affects multiple organ systems at once.
Cutaneous (discoid) lupus is limited to the skin. It causes rashes and lesions but does not affect internal organs.
Drug-induced lupus is a lupus-like condition triggered by certain prescription medications. Symptoms typically resolve once the medication is stopped.
Neonatal lupus is rare and affects newborns whose mothers carry certain lupus-related antibodies. The mother’s antibodies cross the placenta and act on the infant during pregnancy.
Who Gets Lupus
Women of childbearing age, between 15 and 44, face the highest risk. The strong gender gap is partly explained by estrogen, which enhances immune activity. Women naturally produce more estrogen than men, giving them stronger immune responses overall, but that same strength can tip into autoimmunity.
Lupus also disproportionately affects certain racial and ethnic groups. Black and American Indian/Alaska Native women are two to three times more likely than white women to develop the disease. Hispanic and Asian populations also face higher rates. Genetic variations in how the body clears immune complexes and manages inflammation differ across ethnic groups, which helps explain these disparities.
Common Symptoms
Lupus symptoms vary widely from person to person, but the most recognizable ones include:
- Butterfly rash: A rash across both cheeks and the bridge of the nose, often triggered by sun exposure. On darker skin tones, the rash can be harder to spot.
- Joint pain and stiffness: Swelling and morning stiffness lasting 30 minutes or more, typically in two or more joints.
- Persistent fatigue: Often the most debilitating day-to-day symptom.
- Fever: Low-grade fevers without an obvious infection.
- Raynaud’s phenomenon: Fingers and toes turning white or blue in cold temperatures or during stress.
- Chest pain and shortness of breath: Caused by inflammation around the heart or lungs.
- Headaches, confusion, and memory problems: Signs that lupus is affecting the nervous system.
Sunlight is one of the most reliable triggers for skin symptoms and broader flares. Stress, infections, and certain medications can also set off episodes where symptoms intensify.
How Lupus Affects the Kidneys
Kidney involvement is one of the most serious complications. As many as half of adults with SLE develop lupus nephritis, a condition where autoantibodies attack the filtering structures of the kidneys. This can cause protein or blood in the urine, high blood pressure, swelling in the legs and feet, and in severe cases, kidney failure.
Lupus nephritis also raises the risk of cardiovascular problems and certain cancers, particularly B-cell lymphoma. Because kidney damage can progress without obvious early symptoms, people with lupus typically have their kidney function monitored through regular blood and urine tests.
How Lupus Is Diagnosed
There is no single test that confirms lupus. Doctors use a combination of blood tests, symptom history, and physical examination. The first step is usually an antinuclear antibody (ANA) test. A positive ANA result doesn’t mean you have lupus on its own, since many healthy people test positive, but it’s considered a gateway requirement before further evaluation.
From there, clinicians look at a range of clinical signs (rashes, joint involvement, kidney problems, seizures, blood cell abnormalities) and laboratory markers (specific antibodies, complement protein levels). Each finding carries a different weight, and reaching a certain threshold across multiple categories leads to a formal diagnosis. This layered approach exists because lupus mimics many other conditions and no two cases look exactly alike.
Treatment and Daily Management
Lupus has no cure, but treatment can control symptoms and prevent organ damage. The cornerstone medication for most people with lupus is hydroxychloroquine, originally developed as an antimalarial drug. It reduces joint pain and swelling, helps prevent flares, and has been shown to protect against long-term organ damage. Most people take it continuously as a baseline therapy.
Beyond hydroxychloroquine, treatment depends on which organs are involved and how severe the disease is. Mild lupus affecting mainly the skin and joints may need only anti-inflammatory medications. More aggressive disease involving the kidneys or nervous system often requires drugs that suppress the overactive immune response more broadly.
Daily management plays a significant role. Avoiding prolonged sun exposure helps prevent skin flares and broader symptom worsening. Staying physically active, even when joints are stiff, tends to reduce pain and improve mobility over time. Because lupus follows a pattern of flares and remissions, many people feel relatively well between episodes, with treatment focused on extending those quiet periods and reducing the severity of flares when they occur.